Recombinant Human ELMO2 Protein，His

ELMO2 (Engulfment and Cell Motility Protein 2) is a key protein involved in various cellular processes, including cell migration, engulfment of apoptotic cells, and modulation of the immune response. It acts as a link between cytoskeletal dynamics and signaling pathways, particularly by interacting with Rac GTPases. Given its pivotal role in these processes, ELMO2 has garnered attention in the context of several diseases, particularly cancer and neurodegenerative disorders, where aberrant cell motility and impaired clearance of dead cells can lead to disease progression. Research on ELMO2 recombinant proteins aims to elucidate the molecular mechanisms underlying its function and to explore its potential as a therapeutic target. By producing ELMO2 in a recombinant form, scientists can investigate its structure-function relationships, binding interactions with other proteins, and its impact on cellular behavior in controlled experimental settings. Furthermore, understanding the biochemical properties of ELMO2 can pave the way for the development of small molecules or biologics that can modulate its activity, ultimately contributing to innovative treatment strategies for conditions influenced by dysregulated cell motility and immune responses. The exploration of ELMO2 not only enhances our comprehension of fundamental biological processes but also holds promise for advancing personalized medicine approaches in treating various pathologies.